Results 11 to 20 of about 2,206,438 (308)
Nutraceuticals in Neurological Disorders [PDF]
International Journal of Molecular Sciences, 2020 Neurological diseases are one of the major healthcare issues worldwide. Posed lifestyle changes are associated with drastically increased risk of chronic illness and diseases, posing a substantial healthcare and financial burden to society globally. Researchers aim to provide fine treatment for ailing disorders with minimal exposed side effects.
Arun Kumar +2 more
exaly +3 more sources
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
Discover Oncology, 2023 Purpose In the past decade, there has been little progress in the treatment of malignant glioma. Recently, oncolytic virus has made great progress in glioma treatment, and a number of clinical trials have shown their potential of prolonging the survival ...
Shan Jiang +4 more
doaj +1 more source
BMC Medicine, 2023 Background Previous studies have found a correlation between coronavirus disease 2019 (COVID-19) and changes in brain structure and cognitive function, but it remains unclear whether COVID-19 causes brain structural changes and which specific brain ...
Shaojiong Zhou +8 more
doaj +1 more source
Fluids and Barriers of the CNS, 2023 Background The blood brain barrier limits entry of macromolecular diagnostic and therapeutic cargos. Blood brain barrier transcytosis via receptor mediated transport systems, such as the transferrin receptor, can be used to carry macromolecular cargos ...
Thomas J. Esparza +5 more
doaj +1 more source
Paraneoplastic Neurologic Disorders
Current Neurology and Neuroscience Reports, 2023 Abstract Purpose of Review To provide an overview and highlight recent updates in the field of paraneoplastic neurologic disorders. Recent Findings The prevalence of paraneoplastic neurologic disorders is greater than previously reported and the incidence has been rising over time ...
Michael Gilligan +2 more
openaire +2 more sources
Molecular Neurodegeneration, 2022 Triggering receptor expressed on myeloid cells 2 (TREM2) is a single-pass transmembrane immune receptor that is mainly expressed on microglia in the brain and macrophages in the periphery.
Rui-Yang Li +8 more
doaj +1 more source
Driving and Neurologic Disorders [PDF]
Neurology, 2011 Automobile driving is an indispensable activity of daily life. Driving in the United States equates to independence, freedom, and, in most cases, economic livelihood. Yet vehicular crashes injure millions of people in the United States each year at a cost of more than $250 billion, resulting in 40,000 annual deaths.1 Many medical, neurologic, and ...
Joseph F, Drazkowski, Joseph I, Sirven
openaire +2 more sources
Apheresis in Neurological Disorders [PDF]
Journal of Clinical Medicine, 2020 Plasma exchange (PE) and immunoadsorption (IA) constitute important options in the treatment of various autoimmune disorders across different medical disciplines [...]
openaire +3 more sources
Brain and Behavior, 2023 Background The incidence of gastroesophageal reflux disease (GERD) has been shown to be elevated in individuals with epilepsy. Traditional observational studies have led to a limited understanding of the effects of GERD and BE on epilepsy due to the ...
Xiaoduo Liu +8 more
doaj +1 more source
Diagnosis and treatment of paraneoplastic neurological disorders [PDF]
, 2004 In about two thirds of cases, patients with paraneoplastic neurological disorders present to the neurologist without a known tumor. Due to the ongoing immune response, this tumor tends to stay biologically relatively benign, and therefore difficult to ...
Voltz, R., Graus, F.
core +1 more source